Koyfin Home > Directory > Health Care > Akebia Therapeutics > Price / Sales (ntm)

Akebia Therapeutics Price / Sales (ntm) Chart (AKBA)

Akebia Therapeutics annual/quarterly Price / Sales (ntm) from 2014 to 2020.
  • Akebia Therapeutics Price / Sales (ntm) for the quarter ending October 10, 2020 was 1.57 a -16.02% decrease of -0.25 year over year
  • Akebia Therapeutics Price / Sales (ntm) for the last 12 months ending October 10, 2020 was 1.57 a -16.02% decrease of -0.25 year over year
  • Akebia Therapeutics Annual Price / Sales (ntm) for 2020 was 1.57 a -11.97% decrease of -0.19 from 2019
  • Akebia Therapeutics Annual Price / Sales (ntm) for 2020 was 1.76 a -3.14% decrease of -0.06 from 2019
  • Akebia Therapeutics Annual Price / Sales (ntm) for 2020 was 1.81 a -0.46% decrease of -0.01 from 2019
Other Valuation Metrics:
  • Akebia Therapeutics Market Cap for the quarter ending March 03, 2018 was $535m a -24.92% decrease of -133m year over year
  • Akebia Therapeutics Price / Book for the quarter ending March 03, 2018 was 3.80 a -378.76% decrease of -14.40 year over year
  • Akebia Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $217m a -91.84% decrease of -199m year over year
View Chart On Koyfin

Quarterly AKBA Price / Sales (ntm) Data

10/20201.57
10/20201.76
10/20201.81
10/20201.82
10/20201.98
10/20202.05
10/20202.09
10/20202.02
10/20201.98
10/20201.96

Annual AKBA Price / Sales (ntm) Data

20201.57
20201.76
20201.81
20201.82
20201.98
20202.05
20202.09
20202.02
20201.98
20201.96